A stochastic programming approach for clinical trial planning in new drug development

Computers and Chemical Engineering

Volumn 32, Issue 11, 2008, Pages 2626-2642

  Colvin, Matthew ^a   Maravelias, Christos T ^a  

^a University of Wisconsin Madison   (United States)

Author keywords

Mixed integer programming; Optimization under uncertainty; Pharmaceutical research and development; Stochastic programming

Indexed keywords

CHEMOTHERAPY; DRUG DELIVERY; DRUG DOSAGE; MATHEMATICAL PROGRAMMING; PIPELINES; RESEARCH;

CLINICAL TRIALS; DRUG DEVELOPMENTS; ENDOGENOUS UNCERTAINTY; LIMITED RESOURCES; MIXED-INTEGER PROGRAMMING; MULTI-STAGE; OPTIMIZATION UNDER UNCERTAINTY; PHARMACEUTICAL RESEARCH; PHARMACEUTICAL RESEARCH AND DEVELOPMENT; PLANNING PERIOD; POTENTIAL DRUGS; UNCERTAINTY REPRESENTATION;

STOCHASTIC PROGRAMMING;

EID: 45149113095     PISSN: 00981354     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.compchemeng.2007.11.010     Document Type: Article

References (43)

1. Bellman R., and Zadeh L.A. Decision making in a fuzzy environment. Management Science 17 (1970) 141-161
2. Birge J.R., and Louveaux F. Introduction to stochastic programming (1997), Springer, New York
3. Blau G., Mehta B., Bose S., Pekny J., Sinclair G., Keunker K., et al. Risk management in the development of new products in highly regulated industries. Computers & Chemical Engineering 24 (2000) 659-664
4. Blau G.E., Pekny J.F., Varma V.A., and Bunch P.R. Managing a portfolio of interdependent new product candidates in the pharmaceutical industry. Journal of Product Innovation Management 21 4 (2004) 227-245
5. Bose S., and Blau G.E. Use of a network model interface to build spreadsheet models of process systems: A productivity enhancement tool for risk management studies. Computers & Chemical Engineering 24 (2000) 1511-1515
6. Cheng L., Subrahmanian E., and Westerberg A.W. Design and planning under uncertainty: Issues on problem formulation and solution. Computers & Chemical Engineering 27 6 (2003) 781-801
7. Cheng L.F., Subrahmanian E., and Westerberg A.W. Multi-objective decisions on capacity planning and production-inventory control under uncertainty. Industrial & Engineering Chemistry Research 43 9 (2004) 2192-2208
8. Choi J., Realff M.J., and Lee J.H. Dynamic programming in a heuristically confined state space: A stochastic resource-constrained project scheduling application. Computers & Chemical Engineering 28 6/7 (2004) 1039-1058
9. DiMasi J.A., Hansen R.W., and Grabowski H.G. The price of innovation: New estimates of drug development costs. Journal of Health Economics 22 2 (2003)
10. Fu M.C. Optimization for simulation: Theory vs. Practice. INFORMS Journal on Computing 14 3 (2002) 192-215
11. Gatica G., Shah N., and Papageorgiou L.G. An aggregation approach for capacity planning under uncertainty for the pharmaceutical industry. Proceedings of the FOCAPO 2003 (2003), Coral Springs, Florida
12. Goel V., and Grossmann I.E. A stochastic programming approach to planning of offshore gas field developments under uncertainty in reserves. Computers & Chemical Engineering 28 8 (2004) 1409-1429
13. Goel V., and Grossmann I.E. A class of stochastic programs with decision dependent uncertainty. Mathematical Programming 108 2/3 (2006) 355-394
14. Goel V., Grossmann I.E., El-Bakry A.S., and Mulkay E.L. A novel branch and bound algorithm for optimal development of gas fields under uncertainty in reserves. Computers & Chemical Engineering 30 6/7 (2006) 1076-1092
15. Grossmann I.E. Challenges in the new millennium: Product discovery and design, enterprise and supply chain optimization, global life cycle assessment. Computers & Chemical Engineering 29 (2004) 29-39
16. Grossmann I.E., and Westerberg A.W. Research challenges in process systems engineering. AIChE Journal 46 9 (2000) 1700-1703
17. Gupta A., and Maranas C.D. Real-options-based planning strategies under uncertainty. Industrial & Engineering Chemistry Research 43 14 (2004) 3870-3878
18. Honkomp S.J., Reklaitis G.V., and Pekny G.F. Robust planning and scheduling of process development projects under stochastic conditions. Proceedings of the AIChE annual meeting. Los Angeles, CA (1997)
19. Jain V., and Grossmann I.E. Resource-constrained scheduling of tests in new product development. Industrial & Engineering Chemistry Research 38 (1999) 3013-3026
20. Jonsbraten T.W., Wets R.J.B., and Woodruff D.L. A class of stochastic programs with decision dependent random elements. Annals of OR 82 (1998) 83-106
21. Kall P., and Wallace S.W. Stochastic programming (1994), John Willey and Sons, Chichester, England
22. Levis A.A., and Papageorgiou L.G. A hierarchical solution approach for multi-site capacity planning under uncertainty in the pharmaceutical industry. Computers & Chemical Engineering 28 5 (2004) 707-725
23. Maravelias C.T., and Grossmann I.E. Simultaneous planning for new product development and batch manufacturing facilities. Industrial & Engineering Chemistry Research 40 (2001) 6147-6164
24. Maravelias C.T., and Grossmann I.E. Optimal resource investment and scheduling of tests for new product development. Computers & Chemical Engineering 28 (2004) 1021-1038
25. Papageorgiou L.G., Rotstein G.E., and Shah N. Strategic supply chain optimization for the pharmaceutical industries. Industrial & Engineering Chemistry Research 40 1 (2001) 275-286
26. Puterman M.L. Markov decision processes: Discrete stochastic dynamic programming (1994), John Wiley, New York
27. Robins-Roth C. From Alchemy to IPO: The business of biotechnology (2001), Perseus Publishing
28. Rogers M.J., Gupta A., and Maranas C.D. Real options based analysis of optimal pharmaceutical research and development portfolios. Industrial & Engineering Chemistry Research 41 25 (2002) 6607-6620
29. Rogers M.J., Maranas C.D., and Ding M. Valuation and design of pharmaceutical R&D licensing deals. AIChE Journal 51 1 (2005) 198-209
30. Rotstein G.E., Papageorgiou L.G., Shah N., Murphy D.C., and Mustafa R. A product portfolio approach in the pharmaceutical industry. Computers & Chemical Engineering 23 (1999) S883-S886
31. Sahinidis N.V. Optimization under uncertainty: State-of-the-art and opportunities. Computers & Chemical Engineering 28 6/7 (2004) 971-983
32. Schmidt C.W., and Grossmann I.E. Optimization models for the scheduling of testing tasks in new product development. Industrial & Engineering Chemistry Research 35 (1996) 3498-3510
33. Shah N. Pharmaceutical supply chains: Key issues and strategies for optimization. Computers & Chemical Engineering 28 (2004) 929-941
34. Stephanopoulos, G. (2004). Invention and innovation in a product-centered chemical industry. Webcast Lecture, CAST (www.castdiv.org/WebCAST.htm).
35. Stewart J.J., Allison P.N., and Johnson R.S. Putting a price on biotechnology. Nature Biotechnology 19 (2001)
36. Stonebraker J.S. How Bayer makes decisions to develop new drugs. Interfaces 32 6 (2002) 77-90
37. Storck W.J. Chemical earnings climb continues. Chemical and Engineering News 83 21 (2005, May 23)
38. Struck M.M. Biopharmaceutical R&D success rates and development times. Bio Technology 12 (1994)
39. Subramanian D., Pekny J.F., and Reklaitis G.V. A simulation-optimization framework for research and development pipeline management. AIChE Journal 47 10 (2001) 2226-2242
40. Subramanian D., Pekny J.F., Reklaitis G.V., and Blau G.E. Simulation-optimization framework for stochastic optimization of R&D pipeline management. AIChE Journal 49 1 (2003) 96-112
41. Tufts Center for the Study of Drug Development, 2001.
42. Varma V.A., Pekny J.F., Reklaitis G.V., and Subramanian D. An XML-based language for the Research & Development pipeline management problem. Computers & Chemical Engineering 27 10 (2003) 1361-1379
43. Wendt M., Li P., and Wozny G. Nonlinear chance constrained process optimization under uncertainty. Industrial & Engineering Chemistry Research 41 (2002) 3621-3630